Brief: Regulus Therapeutics Inc - Sanofi Delivered Written Notice To Co To Terminate Second Amended, Restated Collaboration, License Agreement
Jan 6 (Reuters) - Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS INC - SANOFI DELIVERED WRITTEN NOTICE
TO CO
TO TERMINATE SECOND AMENDED, RESTATED COLLABORATION, LICENSE
AGREEMENT
* REGULUS THERAPEUTICS INC - IN ACCORDANCE WITH AGREEMENT,
TERMINATION WILL BECOME EFFECTIVE ON FEBRUARY 5, 2023
Further company coverage: RGLS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview